IONS Eugene Schneider sells $409K worth of shares
Aug 06, 2025, 4:36 AM
0.00%
What does IONS do
Ionis Pharmaceuticals, headquartered in Carlsbad, California, develops drugs using antisense technology and has five marketed medicines, including SPINRAZA and QALSODY, with a pipeline focused on neurology and cardiology. The company employs 927 people and has nine medicines in Phase III development.
Eugene Schneider sold 9,549 shares of IONS on 4 August at $42.80 per share, worth a total of $409K. They now own 51,507 IONS shares, or a 16% holding decrease.
📡️ Health Care
Insider Trades
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.